Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0000930413-08-000580

Options or other derivatives

  • Director acquired 90,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Dash Barry H · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Underlying Owned after D/I
2008-01-24 Grant or award : show line 1 in the form Options +90,000 $1.08 $97,200 $1.08 90,000 120,000 D
Loading xslF345X02/c52139_ex.xml…